Article
Noncoding regulatory mutations contribute to the aberrant gene expression in neuroblastoma.
2026-08-15
Abstract excerpt
Comprehensive analyses of whole-genome and exome sequencing data from high-risk neuroblastoma tumors have revealed relatively few recurrent, clinically actionable protein-coding driver mutations at initial diagnosis. This observation suggests that noncoding genetic variation, which can alter regulatory sequences like promoters, enhancers and insulators and influence gene expression, may play a critical role in neu...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7a2b9182-9770-5ce1-b94e-0f0533a6027f
- DOI
- 10.64898/2026.08.10.743941
